Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Daeipour, G. Kumar, M. Amaral, A. Nel (1993)
Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10.Journal of immunology, 150 11
R. Mitchell, C. Metz, Tina Peng, R. Bucala (1999)
Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF)The Journal of Biological Chemistry, 274
M. Bacher, C. Metz, T. Calandra, K. Mayer, Jason Chesney, M. Lohoff, D. Gemsa, T. Donnelly, R. Bucala (1996)
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.Proceedings of the National Academy of Sciences of the United States of America, 93 15
Derek Lacey, A. Sampey, R. Mitchell, R. Bucala, Lanie Santos, M. Leech, E. Morand (2003)
Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor.Arthritis and rheumatism, 48 1
J. Nishihira† (2000)
Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 20 9
M. Naujokas, L. Arneson, B. Fineschi, M. Peterson, S. Sitterding, A. Hammond, C. Reilly, David Lo, Jim Miller (1995)
Potent effects of low levels of MHC class II-associated invariant chain on CD4+ T cell development.Immunity, 3 3
A. Sant, S. Cullen, B. Schwartz (1985)
Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins.Journal of immunology, 135 1
T. Roger, J. David, M. Glauser, T. Calandra (2001)
MIF regulates innate immune responses through modulation of Toll-like receptor 4Nature, 414
Nataliya Panchuk-Voloshina, R. Haugland, J. Bishop-Stewart, M. Bhalgat, P. Millard, F. Mao, W. Leung, R. Haugland (1999)
Alexa Dyes, a Series of New Fluorescent Dyes that Yield Exceptionally Bright, Photostable ConjugatesJournal of Histochemistry & Cytochemistry, 47
D. Matza, O. Wolstein, R. Dikstein, I. Shachar (2001)
Invariant Chain Induces B Cell Maturation by Activating a TAFII105-NF-κB-dependent Transcription Program*The Journal of Biological Chemistry, 276
S. Donnelly, C. Haslett, P. Reid, I. Grant, W. Wallace, C. Metz, L. Bruce, R. Bucala (1997)
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndromeNature Medicine, 3
T. Calandra, JLirgen Bernhagen, R. Mitchell, R. Bucala (1994)
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factorThe Journal of Experimental Medicine, 179
K. Yamasaki, T. Taga, Y. Hirata, H. Yawata, Y. Kawanishi, B. Seed, T. Taniguchi, T. Hirano, T. Kishimoto (1988)
Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.Science, 241 4867
Cesar Castro, Yongping Yang, Zhongjian Zhang, R. Linnoila (2000)
Attenuation of Pulmonary Neuroendocrine Differentiation in Mice Lacking Clara Cell Secretory ProteinLaboratory Investigation, 80
J. Bernhagen, R. Mitchell, T. Calandra, W. Voelter, A. Cerami, R. Bucala (1994)
Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).Biochemistry, 33 47
E. Rubinstein, F. Naour, C. Lagaudrière-Gesbert, M. Billard, H. Conjeaud, C. Boucheix (1996)
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA‐DR and VLA integrinsEuropean Journal of Immunology, 26
Jfirgen Bernhagen, M. Bacher, T. Calandra, C. Metz, Steven Doty, Thomas DonneHy, R. Bucala (1996)
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reactionThe Journal of Experimental Medicine, 183
R. Kleemann, A. Hausser, Georg Geiger, R. Mischke, A. Burger-Kentischer, O. Flieger, F. Johannes, T. Roger, T. Calandra, A. Kapurniotu, M. Grell, D. Finkelmeier, H. Brunner, J. Bernhagen (2000)
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1Nature, 408
B. Arunachalam, Carilee Lamb, Peter Cresswell (1994)
Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.International immunology, 6 3
B. Loddenkötter, B. Kammerer, K. Fischer, U. Flügge (1993)
Expression of the functional mature chloroplast triose phosphate translocator in yeast internal membranes and purification of the histidine-tagged protein by a single metal-affinity chromatography step.Proceedings of the National Academy of Sciences of the United States of America, 90
(2000)
MIF. In Cytokine Reference
M. Strubin, Eric Long, B. Mach (1986)
Two forms of the la antigen-associated invariant chain result from alternative initiations at two in-phase AUGsCell, 47
M. Leech, C. Metz, R. Bucala, E. Morand (2000)
Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis.Arthritis and rheumatism, 43 4
A. Sampey, P. Hall, Robert Mitchell, Christine Metz, E. Morand (2001)
Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor.Arthritis and rheumatism, 44 6
C. Henne, F. Schwenk, N. Koch, P. Möller (1995)
Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.Immunology, 84 2
M. Theis, Thomas Magin, A. Plum, Klaus Willecke (2000)
General or cell type-specific deletion and replacement of connexin-coding DNA in the mouse.Methods, 20 2
Jonathan Ashman, Jim Miller (1999)
A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain.Journal of immunology, 163 5
A. Satoskar, M. Bozza, Miriam Sosa, Guoshing Lin, J. David (2001)
Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major InfectionInfection and Immunity, 69
E. Rosengren, R. Bucala, P. Åman, L. Jacobsson, G. Odh, C. Metz, H. Rorsman (1996)
The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization ReactionMolecular Medicine, 2
R. Donn, Z. Alourfi, F. Benedetti, C. Meazza, E. Zeggini, M. Lunt, A. Stevens, E. Shelley, R. Lamb, W. Ollier, W. Thomson, D. Ray (2002)
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.Arthritis and rheumatism, 46 9
R. Kleemann, R. Mischke, A. Kapurniotu, H. Brunner, J. Bernhagen (1998)
Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processesFEBS Letters, 430
J. Lesley, R. Hyman, P. Kincade (1993)
CD44 and its interaction with extracellular matrix.Advances in immunology, 54
T. Calandra, B. Echtenacher, D. Roy, J. Pugin, C. Metz, L. Hültner, D. Heumann, D. Männel, R. Bucala, M. Glauser (2000)
Protection from septic shock by neutralization of macrophage migration inhibitory factorNature Medicine, 6
J. Chesney, C. Metz, M. Bacher, Tina Peng, A. Meinhardt, R. Bucala (1999)
An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a Murine LymphomaMolecular Medicine, 5
C. Mackenzie, T. Hirama (2000)
Quantitative analyses of binding affinity and specificity for glycolipid receptors by surface plasmon resonance.Methods in enzymology, 312
R. Kleemann, A. Kapurniotu, R. Mischke, J. Held, J. Bernhagen (2001)
Characterization of catalytic centre mutants of macrophage migration inhibitory factor (MIF) and comparison to Cys81Ser MIF.European journal of biochemistry, 261 3
M. Naujokas, M. Morin, Mark Anderson, M. Peterson, Jim Miller (1993)
The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44Cell, 74
T. Calandra, J. Bernhagen, C. Metz, Lori Spiegel, M. Bacher, T. Donnelly, A. Cerami, R. Bucala (1995)
MIF as a glucocorticoid-induced modulator of cytokine productionNature, 377
I. Shachar, R. Flavell (1996)
Requirement for Invariant Chain in B Cell Maturation and FunctionScience, 274
J. Hudson, M. Shoaibi, R. Maestro, A. Carnero, G. Hannon, D. Beach (1999)
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor ActivityThe Journal of Experimental Medicine, 190
J. David (1966)
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.Proceedings of the National Academy of Sciences of the United States of America, 56 1
S. Jüttner, J. Bernhagen, C. Metz, M. Röllinghoff, R. Bucala, A. Gessner (1998)
Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.Journal of immunology, 161 5
P. Senter, Y. Al-Abed, C. Metz, F. Benigni, R. Mitchell, J. Chesney, Jianlin Han, Carlos Gartner, S. Nelson, G. Todaro, R. Bucala (2002)
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolitesProceedings of the National Academy of Sciences of the United States of America, 99
M. Swope, E. Lolis (1999)
Macrophage migration inhibitory factor: cytokine, hormone, or enzyme?Reviews of physiology, biochemistry and pharmacology, 139
R. Mitchell, Hong Liao, J. Chesney, G. Fingerle-Rowson, J. Baugh, J. David, R. Bucala (2001)
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune responseProceedings of the National Academy of Sciences of the United States of America, 99
N. Koch, A. Harris (1984)
Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development.Journal of immunology, 132 1
C. Wraight, P. Endert, Peter Möller, J. Lipp, N. Ling, I. Maclennan, N. Koch, G. Moldenhauer (1990)
Human major histocompatibility complex class II invariant chain is expressed on the cell surface.The Journal of biological chemistry, 265 10
A. Takahashi, K. Iwabuchi, Masaki Suzuki, K. Ogasawara, J. Nishihira†, K. Onoé (1999)
Antisense Macrophage Migration Inhibitory Factor (MIF) Prevents Anti‐IgM Mediated Growth Arrest and Apoptosis of a Murine B Cell Line by Regulating Cell Cycle ProgressionMicrobiology and Immunology, 43
W. Weiser, P. Temple, J. Witek-Giannotti, H. Remold, S. Clark, J. David (1989)
Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.Proceedings of the National Academy of Sciences of the United States of America, 86 19
J. Daun, J. Cannon (2000)
Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBαAmerican Journal of Physiology-regulatory Integrative and Comparative Physiology, 279
A. Jasanoff, G. Wagner, D. Wiley (1998)
Structure of a trimeric domain of the MHC class II‐associated chaperonin and targeting protein IiThe EMBO Journal, 17
P. Cresswell (1994)
Assembly, transport, and function of MHC class II molecules.Annual review of immunology, 12
M. Bozza, A. Satoskar, Guosheng Lin, B. Lu, A. Humbles, C. Gerard, J. David (1999)
Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in SepsisThe Journal of Experimental Medicine, 189
Y. Jong (2002)
Development of chronic colitis is dependent on the cytokine MIFNature Immunology, 3
K. Bendrat, Y. Al-Abed, D. Callaway, Tina Peng, T. Calandra, C. Metz, R. Bucala (1997)
Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.Biochemistry, 36 49
A. Hermanowski‐Vosatka, S. Mundt, J. Ayala, S. Goyal, W. Hanlon, R. Czerwinski, S. Wright, C. Whitman (1999)
Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration.Biochemistry, 38 39
A. D’Andrea, H. Lodish, G. Wong (1989)
Expression cloning of the murine erythropoietin receptorCell, 57
B. Bloom, Boyce Bennett (1966)
Mechanism of a Reaction in Vitro Associated with Delayed-Type HypersensitivityScience, 153
Michelle Leech, Christine Metz, P. Hall, Paul Hutchinson, Katerina Gianis, Malcolm Smith, H. Weedon, S. Holdsworth, R. Bucala, Eric Morand (1999)
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.Arthritis and rheumatism, 42 8
S. Donnelly, R. Bucala (1997)
Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease.Molecular medicine today, 3 11
C. Nathan, H. Remold, J. David (1973)
CHARACTERIZATION OF A LYMPHOCYTE FACTOR WHICH ALTERS MACROPHAGE FUNCTIONSThe Journal of Experimental Medicine, 137
M. George, J. Vaughan (1962)
In vitro Cell Migration as a Model for Delayed Hypersensitivity.∗Proceedings of the Society for Experimental Biology and Medicine, 111
J. Bernhagen, T. Calandra, R. Mitchell, S. Martin, K. Tracey, W. Voelter, K. Manogue, A. Cerami, R. Bucala (1993)
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemiaNature, 365
J. Baugh, S. Chitnis, S. Donnelly, J. Monteiro, Xinchun Lin, B. Plant, F. Wolfe, P. Gregersen, R. Bucala (2002)
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritisGenes and Immunity, 3
Macrophage migration inhibitory factor (MIF) accounts for one of the first cytokine activities to have been described, and it has emerged recently to be an important regulator of innate and adaptive immunity. MIF is an upstream activator of monocytes/macrophages, and it is centrally involved in the pathogenesis of septic shock, arthritis, and other inflammatory conditions. The protein is encoded by a unique but highly conserved gene, and X-ray crystallography studies have shown MIF to define a new protein fold and structural superfamily. Although recent work has begun to illuminate the signal transduction pathways activated by MIF, the nature of its membrane receptor has not been known. Using expression cloning and functional analysis, we report herein that CD74, a Type II transmembrane protein, is a high-affinity binding protein for MIF. MIF binds to the extracellular domain of CD74, and CD74 is required for MIF-induced activation of the extracellular signal–regulated kinase–1/2 MAP kinase cascade, cell proliferation, and PGE 2 production. A recombinant, soluble form of CD74 binds MIF with a dissociation constant of ∼9 × 10 −9 K d , as defined by surface plasmon resonance (BIAcore analysis), and soluble CD74 inhibits MIF-mediated extracellular signal–regulated kinase activation in defined cell systems. These data provide a molecular basis for MIF's interaction with target cells and identify it as a natural ligand for CD74, which has been implicated previously in signaling and accessory functions for immune cell activation. cytokine invariant chain macrophage migration inhibitory factor MAP kinase receptor Footnotes ↵ * Abbreviations used in this paper: Alexa-MIF, Alexa-488–modified MIF; ERK, extracellular signal–regulated kinase; MIF, macrophage migration inhibitory factor; sCD74, soluble CD74. Submitted: 21 February 2003 Accepted: 27 March 2003 Revision received 21 February 2003
The Journal of Experimental Medicine – Rockefeller University Press
Published: Jun 2, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.